BSEParmax Pharma LtdHighPositive
Announced Wed, 2 Sept, 2026 · 10:47 IST
Promoters get preferential shares, direct holding slips below 50%
Price reaction
Awaiting price reaction for this filing.
AI summary
Promoter group of Parmax Pharma acquired 22,80,444 equity shares and 17,16,574 warrants via preferential allotment on August 29, 2026. Direct shareholding fell from 58.01% to 49.32% on expanded capital, slipping below 50%. Including warrants, total potential voting power stands at 68.34%.
Likely market impact
Promoters diluted below 50% direct stake but still control the firm; warrants add future voting power; signals promoter backing of growth